Reported Oct 5, 2016 · Terminated
DRI Salicylate Serum Tox Assay, Catalog number 0977. Toxicology: The DRI Salicylate Serum Tox Assay is intended for the…
Microgenics Corporation
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Microgenics Corporation · 46500 Kato Rd · Fremont, CA · 94538-7310
Is this the product you have?
- DRI Salicylate Serum Tox Assay, Catalog number 0977
- ToxicologyThe DRI Salicylate Serum Tox Assay is intended for the quantitative determination of salicylate in human serum or plasma
- Lot codes and dates
Lot Number Expiration Date 60704602 DEC 201672035410 JUL 201772208738 FEB 201872409454 OCT 2018
- Amount recalled
- 1708 kits
Where it was sold
Why it was recalled
Some lots of DRI Salicylate Serum Tox Assay negative patient samples are recovering higher than the product sensitivity claim of 4.4 mg/dL.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Microgenics Corporation recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.